在哥伦比亚,用linezolid治疗呼吸机相关肺炎的成本效益
Jefferson Antonio Buendía1,2, Diana Guerrero Patiño3, Andrés Felipe Zuluaga Salazar3,4
1Department of Pharmacology and Toxicology, Facultad de Medicina, Universidad de Antioquia, Medellin, Colombia. jefferson.buendia@gmail.com.
BMC infectious diseases
|January 18, 2024
概括
在哥伦比亚,线 (Linezolid,LZD) 是一种更具成本效益的呼吸器相关性肺炎 (VAP) 治疗方法,而不是万科米辛 (vancomycin,VCM). LZD提供更高的治愈率和更低的成本,使其成为VAP管理的首选选项.
科学领域:
- 药物经济学 药物经济学
- 传染性疾病 传染性疾病
- 关键护理医学 关键护理医学
背景情况:
- 呼吸机相关肺炎 (VAP) 是重症监护室 (ICU) 中死亡的一个重要原因.
- 越来越多的甲素耐药黄金葡萄球菌 (MRSA) 感染需要评估替代品.
- 在哥伦比亚,Linezolid (LZD) 的成本效益对抗VCM进行了评估.
研究的目的:
- 为了评估线化物 (LZD) 与菌素 (VCM) 在哥伦比亚治疗VAP的成本效益.
- 为了确定LZD的潜在更高的初始成本是否可以通过改善患者的治疗结果和减少整体医疗保健费用来证明是合理的.
主要方法:
- 一个决策树模型模拟了LZD和VCM治疗的成本和治愈比例.
- 进行了概率分析和信息价值分析.
- 成本效益被评估在5180美元的支付意愿门.
主要成果:
- 与万科米辛 (VCM) 相比,线化物 (LZD) 的成本较低 (平均增量成本为517美元).
- LZD的治愈率 (53%) 与VCM (43%) 相比较高,平均增量效益为10%.
- 有99.9%的概率,LZD比VCM更具成本效益,在敏感性分析中得到了强有力的结果.
结论:
- 在哥伦比亚,Linezolid (LZD) 是一种具有成本效益的策略,用于管理哥伦比亚成年患者的VAP.
- 结果支持LZD作为首选的治疗选择,可能改善临床实践指南和患者的治疗结果.
更多相关视频
11:17Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
12.9K
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
14.7K
相关概念视频
01:28Pneumonia IV: Management
331
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
331
01:28Pulmonary Tuberculosis V
180
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
180